Chemotherapy: 1,904 Real Stories

1,904 stories match chemotherapy. 1,436 of them mention surgery.

Kelsey, who was diagnosed with Stage II Breast CancerBreast Cancer

Finding A Lump To BREAST CANCER!

Patient Info: Kelsey Harrison, Female, Under 40 | Stage II

Biomarkers: ER-positive

As of July 2024, Kelsey had completed chemotherapy, double mastectomy with axillary lymph-node removal, and radiation, and was continuing tamoxifen plus Lupron ovarian suppression with additional planned systemic therapy.

The Patient Story
OutcomeCare Ongoing
A patient, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer Treatment Complicated by Scleroderma-Like Skin Changes

Patient Info: Anonymized, female, 50s | Stage II

Biomarkers: ER low-positive; PR-negative; HER2-negative

Her cancer remained stable during combination treatment. After morphea-like skin changes developed during therapy, treatment was modified and the skin condition improved 6 months after docetaxel was stopped.

PubMed Central
OutcomeCare Ongoing
Lenny, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

Stage IV Non-Small Cell Lung Cancer: Lenny's Survivor Story

Patient Info: Lenny, Male, 50s | Stage IV

Biomarkers: PD-L1 expression positive

Metastatic Site: right femur; brain/cerebellum

As of July 2024, Lenny described himself as NED/no evidence of disease after surgery, CyberKnife radiation, chemotherapy, and Keytruda-based immunotherapy.

The Patient Story
OutcomeCancer-Free / NED
LaShae, who was diagnosed with Breast CancerBreast Cancer

HR-Positive Breast Cancer: LaShae's Patient Story

Patient Info: LaShae, Female, Under 40

Biomarkers: ER-positive; MammaPrint high-risk recurrence; 70-gene hereditary cancer panel negative

As of June 2024, LaShae had completed mastectomy and was undergoing TC chemotherapy, with radiation and long-term hormonal therapy planned; no remission or NED status was stated.

The Patient Story
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Small Cell Lung CancerLung Cancer

Five-year survival with extensive-stage small cell lung cancer on atezolizumab

Patient Info: Anonymized, Male, 50s | Stage IV

Metastatic Site: bilateral lungs, cervical lymph nodes

Five years after diagnosis with extensive-stage small cell lung cancer, he was alive and well on maintenance atezolizumab with no further documented progression after the 2020–2021 rechallenge, reaching 60 months overall survival and about 44 months progression-free survival.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Colon cancer that later spread to the testis and liver

Patient Info: Anonymized, male, 60s | Stage IV

Metastatic Site: right testis, liver

Liver metastasis was found 6 months after orchiectomy. Telephone follow-up confirmed that he survived for more than 18 months after the testicular surgery.

PubMed Central
OutcomeSetback / Progression
A patient, who was diagnosed with Stage III Non-Small Cell Lung CancerLung Cancer

Stage IIIA NSCLC: recurrence-free after surgery, adjuvant chemotherapy, and one atezolizumab dose

Patient Info: Anonymized, Female, 60s | Stage III

Biomarkers: PD-L1 expression 20% by 22C3 assay

She remained free of lung-cancer recurrence for more than 1 year after surgery and adjuvant cisplatin/vinorelbine; atezolizumab was stopped after 1 dose because of severe immune-related toxicities that improved with steroid and immunoglobulin treatment.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV triple-negative breast cancer in remission: CBD and exercise for neuropathy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: Triple-negative breast cancer. Blood and immune inflammation measures were tracked during neuropathy care.

Metastatic Site: liver

She was in remission for more than 5 years after Stage IV breast cancer with a solitary liver metastasis, while later managing chemotherapy-induced peripheral neuropathy with CBD and an exercise program that improved symptoms and function.

PubMed Central
OutcomeCancer-Free / NED
Steve, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Steve's Survivor Story

Patient Info: Steve Slack, Male, 40s | Stage IV

Metastatic Site: liver

As of June 2024, about 6 months after living-donor liver transplant, Steve had a clear surveillance scan and described himself as NED/no evidence of disease.

The Patient Story
OutcomeCancer-Free / NED
Shraddha, who was diagnosed with Ovarian CancerOvarian Cancer

Ovarian Cancer: Shraddha's Patient Story

Patient Info: Shraddha Pandey

Ten years after diagnosis, Shraddha described herself as an ovarian cancer survivor and an advocate for cancer awareness.

AACR
OutcomeNot reported
Sophie, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV BRAF Colorectal Cancer: Sophie's Survivor Story

Patient Info: Sophie, Female | Stage IV

Biomarkers: BRAF-mutated; MSI / microsatellite instability

Metastatic Site: liver; lymph nodes including neck

As of June 2024, Sophie had been off treatment for nearly 3 years and described herself as currently cancer-free after surgery, chemotherapy, immunotherapy, and liver surgery showing no cancer cells.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Lung AdenocarcinomaLung Cancer

EGFR-mutant lung adenocarcinoma in Li-Fraumeni syndrome: relapse-free after lobectomy and chemotherapy

Patient Info: Anonymized, Female, 40s

Biomarkers: Lung tumor had EGFR exon 19 deletion. Germline TP53 variant was consistent with Li-Fraumeni syndrome; prior breast cancers were HER2 positive.

As of July 2024, she was free of relapse 2 years after left inferior lobectomy and pemetrexed/cisplatin for EGFR exon 19 deletion lung adenocarcinoma.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

Stage 3 breast cancer: pathologic complete response to neoadjuvant chemotherapy

Patient Info: Anonymized, Female, Under 40

Biomarkers: ER-positive, PR-negative, HER2-negative breast cancer with very high Ki-67. MammaPrint high-risk/basal type; hereditary testing negative.

Free of recurrence at last follow-up after neoadjuvant pembrolizumab plus chemotherapy, breast-conserving surgery with RCB-0/pathologic complete response, adjuvant radiation, and adjuvant pembrolizumab.

PubMed Central
OutcomeCancer-Free / NED
Liz, who was diagnosed with Stage III Invasive Lobular CarcinomaBreast Cancer

Stage III HR-Positive Invasive Lobular Carcinoma: Liz's Patient Story

Patient Info: Liz O'Riordan, Female, 40s | Stage III

Biomarkers: ER-positive; HER2-negative; PIK3CA mutation reported by patient

As of June 2024, Liz described Stage III ER-positive/HER2-negative mixed ductal and lobular breast cancer followed by 2 locoregional recurrences after mastectomy; no distant metastatic disease was described for her personal story.

YouTube — Dr Liz O'Riordan
OutcomeSetback / Progression
Amy, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Amy's Patient Story

Patient Info: Amy Nicole, Female, Under 40 | Stage IV

Metastatic Site: liver; lymph nodes near kidneys/retroperitoneal lymph…

As of June 2024, Amy was living with recurrent Stage IV colon cancer and was on an immunotherapy clinical trial that improved quality of life compared with chemotherapy, though she did not describe remission or NED.

The Patient Story
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Colorectal AdenocarcinomaColorectal Cancer

Rectal Cancer Relapse With a Rare Kidney Metastasis

Patient Info: Anonymized, Male, Under 40 | Stage IV

Metastatic Site: liver; peritoneum; right kidney

After earlier treatment and a hepatectomy, imaging showed recurrent rectal disease with pelvic and peritoneal involvement and a new right kidney metastasis.

PubMed Central
OutcomeSetback / Progression